30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
Via Federal Register notice, OFCCP has officially stated the Agency- "will not request, accept, or ...
Read More >
In 2019, we saw significant activity in state legislatures passing employment-related laws in areas ...
Read More >
To combat historical imbalances in pay of women and minorities, New Jersey recently passed a bill am...
Read More >
On May 22, 2019, Oregon governor Kate Brown signed House Bill 2341. This bill expands on existing fe...
Read More >
Paid Family Leave - A bill to require paid family leave, H.107, was left on the legislative calenda...
Read More >
The U.K. Competition and Markets Authority (CMA) has published “Guidance on the Functions of the CM...
Read More >